TY - JOUR
T1 - Early life growth trajectories in cystic fibrosis are associated with lung function at age six
AU - Psoter, Kevin J.
AU - Dickinson, Kimberly M.
AU - Riekert, Kristin A.
AU - Collaco, Joseph M.
N1 - Publisher Copyright:
© 2023
PY - 2023/5
Y1 - 2023/5
N2 - Background: Higher growth percentiles are associated with more favorable lung function in cystic fibrosis (CF), prompting the creation of CF Foundation (CFF) nutritional guidelines. Objectives: To describe early childhood growth trajectories within CF, to determine if growth trajectories are associated with differences in lung function at age six, and to identify factors that differ between trajectory groups. Methods: Retrospective cohort study of children diagnosed with CF and born 2000–2011 using the US CFF Patient Registry. Annualized growth parameters prior to age six were included in group-based trajectory modeling to identify unique early life growth trajectories. FEV1 percent predicted (FEV1pp) at age six was compared between trajectory groups using linear regression. Factors associated with group membership were identified using multinomial logistic regression. Results: 6,809 children met inclusion criteria. Six discrete growth trajectories were identified, including three groups that began with growth parameters >50th percentile, termed: “always high”, “gradual decliner”, “rapid decliner”, and three which began with growth parameters <50th percentile, termed: “rapid riser”, “gradual riser”, “always low”. FEV1pp at age six was highest for the Always High trajectory. The Always Low trajectory was nearly 10% lower than the Always High trajectory. Sex, ethnicity, newborn screening and pancreatic function were associated with trajectory class membership. Conclusions: Distinct early life growth trajectories were identified within CF. Trajectories that met CFF nutritional guideline recommendations were associated with higher FEV1pp at age six. CF care teams should continue to partner with families to encourage interventions to support optimal growth to improve lung function in CF.
AB - Background: Higher growth percentiles are associated with more favorable lung function in cystic fibrosis (CF), prompting the creation of CF Foundation (CFF) nutritional guidelines. Objectives: To describe early childhood growth trajectories within CF, to determine if growth trajectories are associated with differences in lung function at age six, and to identify factors that differ between trajectory groups. Methods: Retrospective cohort study of children diagnosed with CF and born 2000–2011 using the US CFF Patient Registry. Annualized growth parameters prior to age six were included in group-based trajectory modeling to identify unique early life growth trajectories. FEV1 percent predicted (FEV1pp) at age six was compared between trajectory groups using linear regression. Factors associated with group membership were identified using multinomial logistic regression. Results: 6,809 children met inclusion criteria. Six discrete growth trajectories were identified, including three groups that began with growth parameters >50th percentile, termed: “always high”, “gradual decliner”, “rapid decliner”, and three which began with growth parameters <50th percentile, termed: “rapid riser”, “gradual riser”, “always low”. FEV1pp at age six was highest for the Always High trajectory. The Always Low trajectory was nearly 10% lower than the Always High trajectory. Sex, ethnicity, newborn screening and pancreatic function were associated with trajectory class membership. Conclusions: Distinct early life growth trajectories were identified within CF. Trajectories that met CFF nutritional guideline recommendations were associated with higher FEV1pp at age six. CF care teams should continue to partner with families to encourage interventions to support optimal growth to improve lung function in CF.
KW - BMI
KW - Cystic fibrosis
KW - Early childhood
KW - FEVpp
KW - Growth trajectories
KW - Registry
KW - WFL
UR - http://www.scopus.com/inward/record.url?scp=85150442576&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85150442576&partnerID=8YFLogxK
U2 - 10.1016/j.jcf.2023.02.008
DO - 10.1016/j.jcf.2023.02.008
M3 - Article
C2 - 36858852
AN - SCOPUS:85150442576
SN - 1569-1993
VL - 22
SP - 395
EP - 401
JO - Journal of Cystic Fibrosis
JF - Journal of Cystic Fibrosis
IS - 3
ER -